Skip to content
Screener

Agilon Health AGL Q2 2025 earnings

Reported August 4, 2025 · After market close

Revenue$1.4BMiss by $76.9M
EPS-$0.25Miss by $0.14
Revenue estimate$1.5B
EPS estimate-$0.11

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$1.5B
EPS estimate-$1.22

Financials

Q2 2025

Income statement

See full
Revenue$1.4B-5.9%
Operating income-$116.0M-168%
Net income-$104.4M-240%
EPS (diluted)-$6.31-8,914%

Balance sheet

See full
Cash & equivalents$171.4M+47.3%
Total debt$41.4M-10.4%
Total equity$408.9M-39.6%
Total assets$1.7B-20.8%

Cash flow

See full
Operating cash flow-$35.1M-87.4%
CapEx$3.3M-1.9%
Free cash flow-$38.3M-74.0%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$914.83M-66.0%
Enterprise value$784.79M-70.0%
P/S0.2×-0.4×

Profitability

See full
Operating margin-6.4%+3.3pp
Net margin-5.3%-0.3pp

Returns & leverage

See full
Return on equity-58.2%+62.0pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Segments

By product

See full
Medical services revenue$1.4B-5.9%
Other operating revenue$2.9M—

FAQ

When did Agilon Health report Q2 2025 earnings?
Agilon Health (AGL) reported Q2 2025 earnings on August 4, 2025 after market close.
What were Agilon Health's Q2 2025 revenue and EPS?
Agilon Health reported revenue of $1.4B and eps of $-0.25 for Q2 2025.
Did Agilon Health beat estimates in Q2 2025?
Revenue missed the consensus estimate of $1.5B by $76.9M. EPS missed the consensus estimate of $-0.11 by $0.14.
How did Agilon Health's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 5.9% from $1.5B a year earlier and eps declined 257.1% from $-0.07.
Where can I find Agilon Health's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-037426) and the 10-Q periodic report (0001628280-25-037430) directly on SEC EDGAR. The filing index links above go to sec.gov.